BioCentury | Jan 13, 2014
Finance

Buyside View XXII: 'Grown up' means growth

Stephen Hansen Senior Writer  An increase in regulatory approvals and new breakthrough therapies has money managers buying into the concept that biotech has entered a new product cycle that provides a strong fundamental basis for...
BioCentury | Jan 6, 2014
Finance

2014 Financial Markets Preview: Hoping the pause is brief

Bankers and buysiders are not expecting a repeat performance of biotech's stellar 2013. But the two dozen who spoke with BioCentury say the capital markets are primed to open back up this month, albeit on...
BC Week In Review | Nov 25, 2013
Financial News

A.P. Pharma completes follow-on

A.P. Pharma Inc. (OTCBB: APPA ), Redwood City, Calif.   Business: Drug delivery   Date completed: 11/20/13   Type: Follow-on   Raised: $60 million   Shares: 150 million   Price: $0.40   Shares after offering:...
BioCentury | Nov 25, 2013
Finance

Highlights of weekly biotech stock moves

Regulatory milestones AB Science S.A. (Euronext:AB) fell €4 (21%) to €15 on Friday after EMA's CHMP issued a negative opinion recommending against approval of an MAA for Masican masitinib to treat gastrointestinal stromal tumors (GIST)...
BC Extra | Nov 21, 2013
Financial News

A.P. Pharma raises $60 million in follow-on

A.P. Pharma Inc. (OTCBB:APPA) raised $60 million through the sale of 150 million shares at $0.40 in a follow-on underwritten by Jefferies; Leerink Swan; JMP Securities; Brean Capital; and Oppenheimer. A.P. Pharma proposed the offering...
BC Week In Review | Nov 11, 2013
Company News

A.P. Pharma management update

A.P. Pharma Inc. (OTCBB:APPA), Redwood City, Calif.   Business: Drug delivery   Hired: Brian Drazba as VP of finance and CFO, formerly VP of finance and chief accounting officer of Ista Pharmaceuticals Inc. , which Bausch...
BC Week In Review | Aug 12, 2013
Financial News

A.P. Pharma financial update

A.P. Pharma's board also approved proposals to change its name to "Heron Therapeutics Inc." and implement a reverse stock split at a ratio between 1-for-10 and 1-to-20. The company will also seek a listing on...
BC Week In Review | May 13, 2013
Company News

A.P. Pharma management update

A.P. Pharma Inc. (OTCBB:APPA), Redwood City, Calif.   Business: Drug delivery   Hired: Steve Davis, a director, as EVP and COO, formerly EVP and COO of Ardea Biosciences Inc. , which AstraZeneca plc acquired; and Barry...
BC Week In Review | Apr 1, 2013
Clinical News

APF530 regulatory update

A.P. Pharma said FDA issued a second complete response letter for an NDA for APF530 to prevent chemotherapy-induced nausea and vomiting (CINV). According to the company, FDA did not request new clinical studies, but did...
BC Week In Review | Dec 17, 2012
Company News

A.P. Pharma management update

A.P. Pharma Inc. (OTCBB:APPA), Redwood City, Calif.   Business: Drug delivery   Hired: Mark Gelder as SVP and CMO, formerly VP and global head of medical affairs at the medical diagnostics business of the GE...
Items per page:
1 - 10 of 93